Greenrise Global Brands Inc (XCX) AI Stock Analysis

• Market Cap: C$472.36K
• Dividend Yield: N/A
• Average Volume (3M): 1.88K
• Price to Earnings (P/E): ―
• Beta (1Y): -4.40
• Revenue Growth: N/A
• EPS Growth: N/A
• Country: CA
• Employees: 200
• Sector: Healthcare
• Sector Strength: 50
• Industry: Drug Manufacturers - Specialty & Generic
• EPS (TTM): >-0.01
• Shares Outstanding: 47,236,040
• 10 Day Avg. Volume: 200
• 30 Day Avg. Volume: 1,883
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): 0.00
• Price to Cash Flow (P/CF): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

The overall stock score is significantly impacted by the company's critical financial condition, characterized by high leverage, negative equity, and cash flow problems. Technical analysis provides a slight positive offset with some short-term momentum, while valuation metrics reinforce concerns due to negative earnings and the lack of dividends.

Greenrise Global Brands Inc Business Overview & Revenue Model

Company Description

Greenrise Global Brands Inc (XCX) is a company operating in the wellness and health sectors, focusing primarily on the development, distribution, and marketing of cannabis and hemp-derived products. The company is committed to providing high-quality, sustainable, and innovative products that cater to a wide range of consumer needs, including medicinal and recreational uses.

How the Company Makes Money

Greenrise Global Brands Inc generates revenue primarily through the sale of its cannabis and hemp-based products. These products are sold through various channels, including direct-to-consumer sales, retail partnerships, and online platforms. The company may also engage in wholesale distribution to other businesses and maintain strategic partnerships with retailers and distributors to expand its market reach. Additional revenue streams can include licensing agreements for their proprietary strains or technologies. Collaboration with research institutions for product development can also contribute to its earnings, along with any ancillary services related to the cannabis industry.

Greenrise Global Brands Inc Financial Statement Overview

Summary

The company is facing severe financial difficulties with no revenue generation and significant losses. It is highly leveraged with negative equity, indicating potential insolvency risks. Cash flow issues are prominent, with consistently negative free cash flow.

Income Statement

The company has shown no revenue in the TTM period and previous years, indicating severe challenges in generating sales. The net income remains negative, and the EBIT and EBITDA are also negative, reflecting operational inefficiencies and substantial losses.

Balance Sheet

The balance sheet reflects a highly leveraged position with a negative stockholders' equity, indicating insolvency risk. The debt-to-equity ratio is extremely high, suggesting financial instability. Additionally, the company has negative equity, which is a significant red flag.

Cash Flow

The company consistently generates negative free cash flow, which has deteriorated further in the TTM period. The operating cash flow is negative, and the free cash flow to net income ratio is undefined due to negative earnings, indicating liquidity issues and poor cash generation.

Breakdown
Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019
Income Statement		Total Revenue
0.00	0.00	452.87K	105.20K	0.00
	Gross Profit
0.00	0.00	43.32K	-153.00	0.00
	EBIT
―	-1.31M	-2.27M	-1.98M	―
	EBITDA
―	-561.08K	-2.23M	-1.98M	0.00
	Net Income Common Stockholders
―	-2.32M	-3.78M	-2.16M	―
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
31.53K	-619.68K	27.45K	60.45K	242.86K
	Total Assets
441.82K	1.25M	252.94K	371.56K	547.98K
	Total Debt
2.80M	3.15M	1.90M	1.08M	366.53K
	Net Debt
2.77M	3.77M	1.87M	1.02M	150.14K
	Total Liabilities
3.06M	3.56M	2.26M	1.34M	639.12K
	Stockholders Equity
-2.61M	-2.32M	-2.00M	-972.61K	―
Cash Flow		Free Cash Flow
199.35K	-1.08M	-1.95M	-1.88M	―
	Operating Cash Flow
199.35K	-1.08M	-1.89M	-1.83M	―
	Investing Cash Flow
387.50K	-531.00K	-63.15K	45.43K	543.70K
	Financing Cash Flow
-534.73K	1.51M	1.92M	1.63M	1.22M

Greenrise Global Brands Inc Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
CURA	57 Neutral	$905.65M	―	-25.08%	―	-0.11%	11.22%
Sector *	52 Neutral	$5.17B	3.59	-42.19%	2.82%	15.05%	-0.04%
ACB	50 Neutral	$348.51M	27.31	4.78%	―	16.39%	-98.10%
OGI	49 Neutral	$190.65M	―	-18.27%	―	7.33%	84.41%
WEED	47 Neutral	$320.53M	―	-84.50%	―	-16.27%	―
XCX	23 Underperform	C$472.36K	―	5.70%	―	―	―